Endocrine Receptor Hub
GLP-1 | GIP | Glucagon | GLP-1 Metabolism Research
metabolic research peptides are organized here as a research-use-only reference for comparing mechanisms, quality documentation, batch traceability, and compound selection across OligoPoly Laboratories research peptides.
Table of Contents
Jump to the comparison tables, compound profiles, quality documentation, FAQ answers, and related OligoPoly Laboratories — Research Division resources.
Endocrine Receptor Ligands Peptides Research Format Comparison
Side-by-side reference table for research-use-only compounds, receptor categories, mechanism class, format, size, and public product access.
| Compound | Receptor | Mechanism | Form | Size | Price |
|---|---|---|---|---|---|
| Tirzepatide | GLP-1 + GIP | Dual agonist | Lyophilized | 10mg vial | $169 |
| Semaglutide | GLP-1 | Selective agonist | Lyophilized | 10mg vial | $149 |
| Retatrutide | GLP-1 + GIP + Glucagon | Triple agonist | Lyophilized | 10mg vial | $219 |
| Cagrilintide | Amylin/CGRP | Long-acting analog | Lyophilized | – | – |
| AOD-9604 | Beta-3 adrenergic | hGH fragment | Lyophilized | 10mg vial | $99 |
| Tesamorelin | GHRH receptor | GHRH analog | Lyophilized | – | – |
Endocrine Receptor Ligands Compound Profiles
Compound cards link directly to product pages and supporting PubMed searches for external research context.
Tirzepatide
Dual incretin pathway compound for GLP-1 and GIP receptor research. OligoPoly connects each lot to COA verification, batch documentation, and research-use-only handling standards.
Key Specs
Receptor: GLP-1 + GIP
Purity: ≥98% target
Form: Lyophilized
COA: Per batch
Semaglutide
Selective GLP-1 receptor pathway peptide used in metabolic research models. OligoPoly connects each lot to COA verification, batch documentation, and research-use-only handling standards.
Key Specs
Receptor: GLP-1
Purity: ≥98% target
Form: Lyophilized
COA: Per batch
Retatrutide
Triple receptor research compound for multi-pathway metabolic signaling review. OligoPoly connects each lot to COA verification, batch documentation, and research-use-only handling standards.
Key Specs
Receptor: GLP-1 + GIP + Glucagon
Purity: ≥98% target
Form: Lyophilized
COA: Per batch
Cagrilintide
Long-acting amylin pathway compound for appetite and metabolic model research. OligoPoly connects each lot to COA verification, batch documentation, and research-use-only handling standards.
Key Specs
Receptor: Amylin/CGRP
Purity: ≥98% target
Form: Lyophilized
COA: Per batch
AOD-9604
hGH fragment 177-191 studied in lipid metabolism and fat metabolism research. OligoPoly connects each lot to COA verification, batch documentation, and research-use-only handling standards.
Key Specs
Receptor: Beta-3 adrenergic
Purity: ≥98% target
Form: Lyophilized
COA: Per batch
Tesamorelin
GHRH analog used in GH-axis and visceral adiposity pathway research. OligoPoly connects each lot to COA verification, batch documentation, and research-use-only handling standards.
Key Specs
Receptor: GHRH receptor
Purity: ≥98% target
Form: Lyophilized
COA: Per batch
Metabolic Pathway Activity Matrix
Receptor and pathway activity coverage across compounds.
| Pathway | Tirzepatide | Semaglutide | Retatrutide | Cagrilintide | AOD-9604 | Tesamorelin |
|---|---|---|---|---|---|---|
| GLP-1 Receptor | ✓ | ✓ | ✓ | – | – | – |
| GIP Receptor | ✓ | – | ✓ | – | – | – |
| Glucagon Receptor | – | – | ✓ | – | – | – |
| Amylin Receptor | – | – | – | ✓ | – | – |
| Beta-3 Adrenergic | – | – | – | – | ~ | – |
| GHRH Receptor | – | – | – | – | – | ✓ |
| Lipid Metabolism | ~ | – | ✓ | – | ✓ | ~ |
| Glucose Regulation | ✓ | ✓ | ✓ | – | – | – |
Key Receptor Systems in Endocrine Receptor Ligands
GLP-1 Receptor System
GLP-1 receptor research evaluates incretin signaling, glucose regulation, and satiety pathway models.
Compounds
Semaglutide, Tirzepatide, Retatrutide
PubMed research searchGIP Receptor System
GIP receptor research helps distinguish dual agonist and triple agonist pathway coverage.
Compounds
PubMed research searchGlucagon Receptor System
Glucagon receptor activity is used to study multi-pathway energy expenditure and hepatic metabolism models.
Compounds
PubMed research searchHalf-Life & Clearance Profiles
Research timing reference for compound clearance, accumulation, and study design.
| Compound | Type | Approximate t1/2 | Accumulation | Notes |
|---|---|---|---|---|
| Tirzepatide | Long-acting | ~5-7 days | Weekly | Review literature and lot documentation before protocol design. |
| Semaglutide | Long-acting | ~5-7 days | Weekly | Review literature and lot documentation before protocol design. |
| Retatrutide | Long-acting | ~5-7 days | Weekly | Review literature and lot documentation before protocol design. |
| Cagrilintide | Long-acting | ~5-7 days | Weekly | Review literature and lot documentation before protocol design. |
| AOD-9604 | Short-acting | ~30 min to several hours | Protocol dependent | Review literature and lot documentation before protocol design. |
| Tesamorelin | Short-acting | ~30 min to several hours | Protocol dependent | Review literature and lot documentation before protocol design. |
Research Protocol Frameworks
Acute Metabolic Dynamics
- Glucose response windows
- Short observation intervals
- Compare GLP-1 and GIP signals
- Use COA-verified lots
Peptide Combination Pathways
- Avoid overlapping mechanisms without rationale
- Document receptor coverage
- Use the compare tool
- Review batch records
Lipid Metabolism & Management
- AOD-9604 and Retatrutide pathway context
- Track lipid-related endpoints
- Define study duration
- Maintain cold storage
Hepatic Glucose Regulation
- Glucagon receptor review
- Insulin/glucose pathway endpoints
- Weekly long-acting designs
- Lot-level traceability
Quality Standards for metabolic research peptides
OligoPoly Laboratories aligns research peptide quality standards with batch-specific documentation, HPLC purity context, mass spectrometry confirmation, and online COA access.
HPLC Review
Purity data are reviewed before batch release and connected to lot-level records.
Mass Spec Identity
Identity confirmation supports research suitability and compound traceability.
COA Access
Use COA verification to match a lot number to documentation.
Quality Standards
Review peptide quality standards for handling and documentation details.
Approved Research Bundles
The Approved Research Bundles presents Retatrutide, AOD-9604, and NAD+ as a multi-pathway research collection for receptor, lipid metabolism, and cellular energy pathway review.
Endocrine Receptor Hub Cluster Articles
Internal research library links support deeper reading and crawlable topic clusters.
GLP-1 Receptor Agonists Overview
Review GLP-1 pathway context and receptor models.
Tirzepatide vs Semaglutide Research Comparison
Compare dual and single receptor strategies.
Retatrutide Triple Agonist Mechanism
Study triple agonist pathway coverage.
AOD-9604 Lipid Metabolism Research
Review lipid metabolism and hGH fragment context.
Metabolic Pathway Research Guide
Map metabolic research pathways.
How GLP-1 Peptides Work in Research Models
Mechanism-focused GLP-1 reference.
Dual vs Triple Receptor Agonist Research
Compare receptor class selection.
Peptide Research Panels for Endocrine Receptor Ligands
Review Research Panel design concepts.
Research Citations & External Databases
PubMed Searches
NIH NLM
NIH National Library of Medicine provides biomedical literature and terminology context for research review.
ClinicalTrials.gov
ClinicalTrials.gov helps researchers review study registrations and public trial context.
Endocrine Receptor Hub FAQs
What are the main GLP-1 research peptides available?
OligoPoly lists Semaglutide, Tirzepatide, and Retatrutide for research-use-only pathway review. Each product should be evaluated with lot-specific COA documentation.
What is the difference between Tirzepatide and Semaglutide in research models?
Tirzepatide is a dual GLP-1/GIP agonist research compound, while Semaglutide is a selective GLP-1 pathway compound. Researchers can also use the peptide comparison tool to review differences.
How does Retatrutide differ from dual agonists?
Retatrutide is studied as a GLP-1/GIP/glucagon triple agonist research compound. That broader receptor coverage may support different metabolic pathway questions than dual agonist models.
What does third-party tested mean for peptide purity?
Third-party testing means an outside lab reviews analytical data such as HPLC and mass spectrometry. Review quality standards and COA verification before selecting a batch.
How are metabolic peptides used in laboratory research?
Metabolic peptides are used in controlled laboratory models to evaluate receptor activity, pathway timing, and compound comparison. They are not intended for human use or self-administration.
What is the purity standard for research peptides?
OligoPoly targets high-purity documentation with HPLC and identity review. The peptide quality standards page explains batch documentation in detail.
Can metabolic research peptides be stacked?
Research Panel research requires a documented hypothesis, receptor rationale, and batch records. Review the Approved Research Bundles and compare individual compounds before protocol planning.
Where can I verify the batch COA for my order?
Use the COA verification page to match the lot or batch ID to available certificate documentation.
Single-Compound Research Materials Referenced in This Guide
For Research Use Only · Third-Party Tested · COA Documentation · Ships from Houston TX

